Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study
Clinical trial NCT02316470 · COMPLETED
Trial details
- NCT number
- NCT02316470
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.